MRI测量的前列腺尿道长度可能预测前列腺癌放疗后晚期泌尿生殖系统毒性
这项单机构回顾性队列研究纳入361例前列腺腺癌患者,评估放疗前6个月内MRI定量测量尿道、前列腺和膀胱指标及临床特征对放疗后泌尿生殖系统(GU)毒性的预测价值。结果显示,较长的前列腺尿道长度与晚期≥2级GU毒性风险升高独立相关(HR 1.6,95%CI 1.2-2.1,P<0.01),尤其与尿频/尿急症状相关(HR 1.7,95%CI 1.3-2.3,P<0.01)。作者认为该治疗前指标可能有助于前列腺放疗后生活质量的风险分层模型。
要点
- 放疗前MRI测量的前列腺尿道长度较长与晚期≥2级GU毒性风险升高独立相关(HR 1.6)。
- 前列腺尿道长度较长尤其与晚期尿频/尿急症状风险升高相关(HR 1.7)。
- 近距离放疗与急性GU毒性几率升高相关(OR 2.9),而较长尿道膜部长度与急性GU毒性几率降低相关(OR 0.41)。
核心结论
- MRI测量的前列腺尿道长度较长与前列腺癌放疗后发生晚期≥2级GU毒性的风险升高独立相关,该治疗前指标可能在前列腺放疗后生活质量的风险分层模型中具有潜在价值。
研究设计与样本
- 单机构回顾性队列研究,纳入2016年6月至2023年2月期间接受根治性放疗并在放疗完成前6个月内行MRI的前列腺腺癌患者361例(中位年龄68岁,IQR 62-73),MRI测量包括尿道、前列腺和膀胱的定量指标。
诊断标准与关键数值
- GU毒性采用CTCAE v4.0由医师评分,急性毒性定义为≤180天,晚期毒性定义为>180天;多因素logistic回归分析急性≥2级毒性,Cox比例风险回归分析晚期毒性,并校正临床因素和放疗方式。
临床应用与阅片要点
- 作者认为治疗前MRI测量的前列腺尿道长度可能有助于前列腺放疗后生活质量的风险分层模型。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: The purpose of our study was to evaluate pretreatment prostate quantitative magnetic resonance imaging (MRI) measurements and clinical characteristics in predicting genitourinary (GU) toxicity after radiotherapy (RT) for prostate cancer.
MATERIALS AND METHODS: In this single-institution retrospective cohort study, we evaluated patients with prostate adenocarcinoma who underwent MRI within 6 months before completing definitive RT and follow-up information in our GU toxicity database from June 2016 to February 2023. MRI measurements included quantitative urethra, prostate, and bladder measurements. GU toxicity was physician-scored using the Common Terminology Criteria for Adverse Events (CTCAE v4.0) with acute toxicity defined as ≤180 days and late defined as >180 days. Multivariable logistic regression model was constructed for grade ≥2 acute toxicity and Cox proportional hazards regression for late toxicity, adjusted for clinical factors and RT method.
RESULTS: A total of 361 men (median age 68 years, interquartile range [IQR] 62-73) were included; 14.4% (50/347) men experienced grade ≥2 acute toxicity. Brachytherapy (odds ratio [OR]: 2.9, 95% confidence interval [CI]: 1.5-5.8), P < 0.01) was associated with increased odds of acute GU toxicity, and longer MUL (OR: 0.41 [95%CI: 0.18-0.92], P = 0.03) with decreased odds. Median follow-up for late toxicity was 15.0 months (IQR: 9.0-28.0) with approximately 88.7% and 72.0% patients free of toxicity at 1 and 3 years, respectively. Only longer prostatic urethral length (hazard ratio [HR]: 1.6, 95%CI: 1.2-2.1, P < 0.01) was associated with increased risk of late GU toxicity, notably urinary frequency/urgency symptoms (HR: 1.7 [95%CI: 1.3-2.3], P < 0.01).
CONCLUSION: Longer prostatic urethral length measured on prostate MRI is independently associated with higher risk of developing late grade ≥2 GU toxicity after radiation therapy for prostate cancer. This pretreatment metric may be potentially valuable in risk-stratification models for quality of life following prostate RT.
引用
- Lee J, Nandalur S, Hazy A, et al. Prostatic Urethral Length on MRI Potentially Predicts Late Genitourinary Toxicity After Prostate Cancer Radiation. Acad Radiol. 2023. PMID: 37858506. doi:10.1016/j.acra.2023.09.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。